Recash test site | Mosegaard Alstrup | Activity https://recash.wpsoul.net/members/atmchild3/activity/ Activity feed for Mosegaard Alstrup. Tue, 19 May 2026 20:03:20 +0000 https://buddypress.org/?v= en-US 30 hourly 2 0695943101c5a7348ee879e59420b9ce Mosegaard Alstrup posted an update: 008 (95% CI 63.8-233.7). In conclusion, PCSK9 inhibitors are […] https://recash.wpsoul.net/activity/p/52957/ Wed, 11 Dec 2024 17:24:12 +0000 008 (95% CI 63.8-233.7). In conclusion, PCSK9 inhibitors are an excellent treatment option in patients with FH who do not reach their LDL-C goals with standard therapy or due to intolerance to the standard therapy. There is no difference in the lipid-lowering effect between both PSCK9 inhibitors.

Controversy surrounds the extent and intensity…[Read more]

]]> 0 0dfa26c3a728aa8608d94e14701d12ed Mosegaard Alstrup became a registered member https://recash.wpsoul.net/activity/p/52776/ Wed, 11 Dec 2024 17:05:39 +0000 0